Listening to Provenge--what a costly cancer treatment says about future Medicare policy

MeSH terms

• Cancer Vaccines / economics
• Cancer Vaccines / therapeutic use*
• Centers for Medicare and Medicaid Services, U.S.*
• Drug Approval / organization & administration*
• Drug Costs
• Health Policy*
• Humans
• Male
• Medicare
• Medicare Part B
• Medicare Part D
• Prostatic Neoplasms / therapy*
• Tissue Extracts / economics
• Tissue Extracts / therapeutic use*
• United States
• United States Food and Drug Administration*